case_images: PMC11699507_01
case_images: Case A: Acne fulminans initial presentation. (A) Photos taken during the patient's first visit, displaying the chest. (B) Photos taken during the patient's first visit, focusing on the back.
case_images: JOCD-24-e16478-g004.jpg
case_images: PMC11699507_01_JOCD-24-e16478-g004.jpg
case_images: jocd16478-fig-0001
case_images: On the examination, inflammatory papules and pustules and painful hemorrhagic nodules with hemorrhagic crusts were observed (Figure 1).
case_images: Case A: Eighteen months follow-up. (A) Follow-up images captured 18 months later, showcasing the chest. (B) Follow-up images captured 18 months later, highlighting the back.
case_images: JOCD-24-e16478-g001.jpg
case_images: PMC11699507_01_JOCD-24-e16478-g001.jpg
case_images: jocd16478-fig-0002
case_images: PMC11699507_02
case_images: Case B: Acne fulminans treatment progression. (A) Onset of the initial isotretinoin treatment. (B) Cessation of the isotretinoin treatment, followed by the commencement of a combined therapy involving antibiotics and steroids. (C) Images displaying the relapse of acne fulminans.
case_images: JOCD-24-e16478-g003.jpg
case_images: PMC11699507_02_JOCD-24-e16478-g003.jpg
case_images: jocd16478-fig-0003
case_images: The patient started on isotretinoin (Aisoskin, Fidia Farmaceutici Spa, Abano Terme, Italy) 20 mg daily (Figure 3). One month post onset of treatment, the patient developed AF with worsening of the cystic acne with voluminous nodular lesion (Figure 3). When the dose was increased to 20 mg the patient had a relapse of AF (Figure 3).
case_images: Case B: Acne Fulminans Improvement Post FLE Treatment. (A) Onset of FLE treatment, following the discontinuation of the previous pharmaceutical approach. (B) Four months after the finalization of the FLE treatment, depicting significant improvements.
case_images: JOCD-24-e16478-g002.jpg
case_images: PMC11699507_02_JOCD-24-e16478-g002.jpg
case_images: jocd16478-fig-0004
case_images: Four months post treatment completion, the patient was still in complete remission (Figure 4).